News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Day In Review: Biotech Climbs Following Fed Hike


10/19/2005 5:12:28 PM

December 14, 2004 -- The Centient Biotech 200™ gained 14.40 to 3528.79, a .40% rise. That was ahead of the NYSE Composite, which added on .31%, and just behind the Nasdaq, which was higher by .53%. We discuss the news about Abbott Labs, Merck, Forest Labs, Xoma and Corixa.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES